Hikma Pharmaceuticals Share News (HIK)

REPEAT: MARKET COMMENT: UK Stocks Close Lower After Roller Coaster Day

MARKET COMMENT: UK Stocks Close Lower After Roller Coaster Day

DIRECTOR DEALINGS: Hikma Pharmaceuticals Chairman Sells Shares

DIRECTOR DEALINGS: Hikma Pharmaceuticals Founder Acquires Shares

BROKER RATING CHANGES: Barclays, Nomura Cut Unilever Price Target

UPDATE 1-Hikma in joint-venture to tap high-growth Ethiopian market

By Paul Sandle LONDON, Sept 18 (Reuters) - Jordan's Hikma Pharmaceuticals has formed a joint venture with Sheikh Mohammed Hussein Al Amoudi's MIDROC Group to enter the Ethiopian healthcare market, where health spending is likely to more than double in the next few years. London-liste

Hikma signs joint venture with MIDROC to enter Ethiopian market

Hikma Pharmaceuticals has signed a joint venture agreement with MIDROC Pharmaceuticals to enter the Ethiopian medicine market. The joint venture, HikmaCure, will establish an Ethiopian operating company, build a local manufacturing facility and begin marketing and distributing pharmaceutical produ

Hikma Pharma teams up with MIDROC to enter Ethiopian market

LONDON, Sept 18 (Reuters) - Jordan's Hikma Pharmaceuticals said on Wednesday it was entering the Ethiopian market through a joint venture with Sheikh Mohammed Hussein Al Amoudi's MIDROC Group. London-listed Hikma said the joint venture, named HikmaCure, would establish an Ethiopian operati

Hikma Pharma Signs JV Agreement With MIDROC Pharma

MARKET COMMENT: UK Equities Firm Ahead Of Central Bank Meetings

London midday: Markets cautious ahead of risk events, Syria action

Traders adopted a cautious approach on Wednesday morning with UK stocks registering losses in morning trade ahead of a number of 'risk events' later in the week which have the potential to spark market volatility. Fears about impending US military action in Syria also hit investor sentiment today a

London open: Potential strike on Syria worries investors early on

Stocks declined on Wednesday morning on concerns over an imminent Western military intervention in Syria, with investors also choosing to scale back positions ahead of a number of 'risk events' later on in the week. The Senate Foreign Relations Committee last night gave the green light on a US atta

MARKET EYE-Sun Pharma gains on better outlook for key drug

* Sun Pharmaceutical Industries Ltd up 1 percent after a competitor raised its revenue guidance, citing strong sale of a generic antibiotic also sold by Sun Pharma. * Hikma Pharmaceuticals Plc on Wednesday raised its full-year revenue forecast for the third time in four months, riding on strong s

Thursday tips round-up: Serco, Hikma Pharmaceuticals, Goals Soccer Centres

The future for outsourcing outfit Serco is now uncertain as the Government calls for a detailed review of all contracts and profit margins are expected to slide. However, its update on trading in the second quarter was good. With long-term government contracts comes steady cash flow, and Serco has b

Thursday broker round-up UPDATE

Aggreko: RBC Capital reduces target price from 1850p to 1680p, while its neutral rating remains unchanged. Aviva: JP Morgan raises target price from 393p to 436p and retains an overweight rating. BHP Billiton: Canaccord Genuity takes target price from 1950p to 2050p maintaining a hold recommendati